The Relationship between Serum Zinc Level and Heart Failure: A Meta-Analysis.
Xuefang YuLei HuangJinyan ZhaoZhuoqun WangWei YaoXianming WuJingjing HuangBo BianPublished in: BioMed research international (2018)
Zinc is essential for the maintenance of normal cellular structure and functions. Zinc dyshomeostasis can lead to many diseases, such as cardiovascular disease. However, there are conflicting reports on the relationship between serum zinc levels and heart failure (HF). The purpose of the present study is to explore the relationship between serum zinc levels and HF by using a meta-analysis approach. PubMed, Web of Science, and OVID databases were searched for reports on the association between serum zinc levels and HF until June 2016. 12 reports with 1453 subjects from 27 case-control studies were chosen for the meta-analysis. Overall, the pooled analysis indicated that patients with HF had lower zinc levels than the control subjects. Further subgroup analysis stratified by different geographic locations also showed that HF patients had lower zinc levels than the control subjects. In addition, subgroup analysis stratified by HF subgroups found that patients with idiopathic dilated cardiomyopathy (IDCM) had lower zinc levels than the control subjects, except for patients with ischemic cardiomyopathy (ICM). In conclusion, the results of the meta-analysis indicate that there is a significant association between low serum zinc levels and HF.
Keyphrases
- oxide nanoparticles
- heart failure
- case control
- systematic review
- acute heart failure
- cardiovascular disease
- end stage renal disease
- chronic kidney disease
- type diabetes
- emergency department
- randomized controlled trial
- metabolic syndrome
- meta analyses
- newly diagnosed
- blood brain barrier
- machine learning
- coronary artery disease
- patient reported outcomes
- electronic health record
- open label
- cerebral ischemia
- phase iii